• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱发天疱疮的药物分子中的活性酰胺基团:一种偶然还是因果关系?

An active amide group in the molecule of drugs that induce pemphigus: a casual or causal relationship?

作者信息

Wolf R, Brenner S

机构信息

Department of Dermatology, Tel-Aviv Sourasky Medical Center, Ichilov Hospital, Israel.

出版信息

Dermatology. 1994;189(1):1-4. doi: 10.1159/000246749.

DOI:10.1159/000246749
PMID:8003774
Abstract

Traditionally, drugs that are capable of inducing pemphigus are divided into two main groups according to their chemical structure, in particular, the existence of a sulfhydryl group in their molecule. Thus, two groups are formed: (1) drugs containing a sulfhydryl radical (thiol drugs or SH drugs) and (2) nonthiol or other drugs. Much emphasis has been put on the role of the sulfhydryl group in the pathogenesis of drug-induced pemphigus. The effects of this group have been extensively studied, and a logical paradigm on the mode of its action has been created. However, no attempt has been made to search for other biochemical radicals which might have an influence on the activation/triggering of this disease. The aim of the present report is to draw attention to a chemical group common to the molecule of several drugs that have been associated with the induction of pemphigus. Careful analysis of the chemical structure of nonthiol drugs known to induce pemphigus revealed that several of them share an active amide group in their molecule. We believe that this group might be responsible for the induction of the disease; thus, a third group of drugs capable of triggering pemphigus can be formed, namely drugs containing an active amide group. Several drugs of this group are discussed.

摘要

传统上,能够诱发天疱疮的药物根据其化学结构,特别是分子中巯基的存在,分为两大类。因此,形成了两组:(1)含有巯基的药物(硫醇类药物或SH药物)和(2)非硫醇类或其他药物。巯基在药物性天疱疮发病机制中的作用受到了高度重视。对该基团的作用进行了广泛研究,并建立了关于其作用方式的合理范式。然而,尚未尝试寻找可能对这种疾病的激活/触发有影响的其他生化基团。本报告的目的是提请注意几种与天疱疮诱发相关的药物分子中共同存在的一个化学基团。对已知能诱发天疱疮的非硫醇类药物的化学结构进行仔细分析后发现,其中几种药物的分子中都有一个活性酰胺基团。我们认为该基团可能是诱发该病的原因;因此,可以形成第三类能够引发天疱疮的药物,即含有活性酰胺基团的药物。本文讨论了该类中的几种药物。

相似文献

1
An active amide group in the molecule of drugs that induce pemphigus: a casual or causal relationship?诱发天疱疮的药物分子中的活性酰胺基团:一种偶然还是因果关系?
Dermatology. 1994;189(1):1-4. doi: 10.1159/000246749.
2
Drug-induced pemphigus. I. A survey.药物性天疱疮。I. 一项调查。
Clin Dermatol. 1993 Oct-Dec;11(4):501-5. doi: 10.1016/0738-081x(93)90157-8.
3
Drug-induced versus drug-triggered pemphigus.药物诱导型与药物触发型天疱疮
Dermatologica. 1991;182(4):207-10. doi: 10.1159/000247795.
4
Pemphigus can be induced by topical phenol as well as by foods and drugs that contain phenols or thiols.天疱疮可由局部应用苯酚以及含有酚类或硫醇类的食物和药物诱发。
J Cosmet Dermatol. 2003 Jul;2(3-4):161-5. doi: 10.1111/j.1473-2130.2004.00098.x.
5
Tracing the origins of active amide group-positive drug-induced pemphigus vulgaris along the Silk Road: a case report of candesartan-induced pemphigus vulgaris and review of nonthiol drug-induced pemphigus.追溯沿丝绸之路出现的活性酰胺基团阳性药物诱发的寻常型天疱疮的起源:一例坎地沙坦诱发的寻常型天疱疮病例报告及非硫醇类药物诱发天疱疮的综述
Int J Dermatol. 2018 Nov;57(11):e131-e134. doi: 10.1111/ijd.14108. Epub 2018 Jul 5.
6
Possible nutritional factors in induced pemphigus.
Dermatology. 1994;189(4):337-9. doi: 10.1159/000246874.
7
Pemphigus serum and captopril induce heat shock protein 70 and inducible nitric oxide synthase overexpression, triggering apoptosis in human keratinocytes.天疱疮血清和卡托普利可诱导热休克蛋白70和诱导型一氧化氮合酶过度表达,从而触发人角质形成细胞凋亡。
Br J Dermatol. 2004 Jun;150(6):1070-80. doi: 10.1111/j.1365-2133.2004.05919.x.
8
Diclofenac: a new trigger of pemphigus vulgaris?双氯芬酸:寻常型天疱疮的一种新诱因?
Dermatology. 1997;195(1):48-9. doi: 10.1159/000245685.
9
Cefadroxil-induced ampicillin-exacerbated pemphigus vulgaris: case report and review of the literature.头孢羟氨苄诱发氨苄西林加重的寻常型天疱疮:病例报告及文献复习
Drug Intell Clin Pharm. 1986 Mar;20(3):219-23. doi: 10.1177/106002808602000309.
10
Pemphigus relapse and acetazolamide, a drug with an active amide group: a casual or causal relationship?天疱疮复发与乙酰唑胺(一种具有活性酰胺基团的药物):偶然还是因果关系?
J Eur Acad Dermatol Venereol. 2009 Jun;23(6):716-7. doi: 10.1111/j.1468-3083.2009.03170.x.

引用本文的文献

1
Drug-Induced Pemphigus Foliaceus Potentially Triggered by Piperacillin-Tazobactam, Linezolid, and Additional Factors: A Report of a Rare Case.哌拉西林-他唑巴坦、利奈唑胺及其他因素可能引发的药物性落叶型天疱疮:1例罕见病例报告
Cureus. 2025 May 31;17(5):e85144. doi: 10.7759/cureus.85144. eCollection 2025 May.
2
An Efficient Greener Approach for -Acylation of Amines in Water Using Benzotriazole Chemistry.一种使用苯并三唑化学在水中高效环保地进行胺的 -酰化反应的方法。
Molecules. 2020 May 28;25(11):2501. doi: 10.3390/molecules25112501.
3
S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
S-取代的 2-巯基喹唑啉-4(3H)-酮和 4-乙基苯磺酰胺类化合物可作为强效和选择性的人碳酸酐酶 IX 和 XII 抑制剂。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):733-743. doi: 10.1080/14756366.2020.1742117.
4
A retrospective study of antihypertensives in pemphigus: a still unchartered odyssey particularly between thiols, amides and phenols.一项关于天疱疮患者使用抗高血压药物的回顾性研究:一段仍未被探索的历程,尤其是在硫醇、酰胺和酚类药物之间。
Arch Med Sci. 2015 Oct 12;11(5):1021-7. doi: 10.5114/aoms.2015.54857.
5
Oral bullous eruption after taking lisinopril--case report and literature review.服用赖诺普利后出现口腔大疱性皮疹——病例报告及文献复习。
Wien Klin Wochenschr. 2013 Jul;125(13-14):408-11. doi: 10.1007/s00508-013-0382-7. Epub 2013 Jun 21.
6
Pemphigus Vulgaris Associated with Rheumatoid Arthritis in a Patient not Taking Penicillamine.一名未服用青霉胺的患者出现寻常型天疱疮合并类风湿关节炎
J Dent Res Dent Clin Dent Prospects. 2012 Winter;6(1):33-5. doi: 10.5681/joddd.2012.008. Epub 2012 Mar 13.
7
D-penicillamine and gold salt treatments were complicated by myasthenia and pemphigus, respectively, in the same patient with rheumatoid arthritis.在同一位类风湿关节炎患者中,D-青霉胺和金盐治疗分别出现了重症肌无力和天疱疮并发症。
Rheumatol Int. 1995;15(3):95-7. doi: 10.1007/BF00302124.